Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
Smithsonian Magazine on MSN

Scientists Reverse Human Rejection of Pig Organ Transplant for First Time Ever

A new study reversed transplant rejection twice, uncovering the reasons for transplant rejection on a cellular level ...